Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oragenics

3.53
-0.1700-4.59%
Post-market: 3.530.00000.00%19:55 EDT
Volume:211.01K
Turnover:768.32K
Market Cap:2.53M
PE:-0.12
High:3.90
Open:3.62
Low:3.34
Close:3.70
Loading ...

Top Premarket Decliners

MT Newswires Live
·
04 Jun

Amex Halt Add Info Lst 6.790000

THOMSON REUTERS
·
03 Jun

Oragenics trading halted, volatility trading pause

TIPRANKS
·
03 Jun

Amex Halt Add Info Lst 5.960000

THOMSON REUTERS
·
03 Jun

Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings

Benzinga
·
02 Jun

Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split

THOMSON REUTERS
·
28 May

Oragenics Hosts Neurotrauma Medicine Webinar Presentation

TIPRANKS
·
21 May

Oragenics, Inc. Announces Approval to Initiate Phase Ii Concussion Drug Trial in Australia

THOMSON REUTERS
·
13 May

BRIEF-Oragenics Announces Health And Disability Ethics Committee Submission

Reuters
·
09 Apr

Oragenics announces HDEC submission for Phase II concussion trial

TIPRANKS
·
09 Apr

Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial

GlobeNewswire
·
09 Apr

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit

GlobeNewswire
·
08 Apr

BRIEF-Oragenics Provides Q1 2025 Shareholder Update On Strategic And Financial Progress

Reuters
·
27 Mar

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

THOMSON REUTERS
·
27 Mar

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

GlobeNewswire
·
27 Mar

Oragenics submits IB for Phase II clinical trial of ONP-002 in mTBI

TIPRANKS
·
06 Mar

Oragenics, Inc. Submits Investigator’s Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury (mTBI)

GlobeNewswire
·
06 Mar

Oragenics CMO to present at Emergencies in Medicine Conference

TIPRANKS
·
25 Feb

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment

GlobeNewswire
·
25 Feb

Press Release: Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health

Dow Jones
·
24 Feb